<DOC>
	<DOCNO>NCT01600755</DOCNO>
	<brief_summary>The aim clinical study investigate safety feasibility Autologous Muscle Derived Cells ( AMDC ; preparation patient 's cell ) injection anal sphincter treatment patient fecal incontinence .</brief_summary>
	<brief_title>Autologous Cell Therapy Treatment Fecal Incontinence</brief_title>
	<detailed_description />
	<mesh_term>Fecal Incontinence</mesh_term>
	<criteria>Primary symptom fecal incontinence , confirm patient medical history physical examination Wexner score â‰¥ 9 Failed conservative treatment Gracilis sling repair insertion artificial sphincter Inflammatory Bowel Disease Significant rectocele rectal prolapse History radiation treatment anal sphincter adjacent structure Less 18 year age Pregnant , breastfeeding , plan become pregnant course study Neuromuscular disorder History neoplasia within 5 year prior enrollment , except basal cell carcinoma , receive plan receive anticancer medication Known bleed diathesis uncorrected coagulopathy Medical condition would preclude treatment due contraindication and/or warning concomitant medication list experimental product label Participating another investigational drug device study Unable unwilling provide inform consent Unable unwilling commit followup procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Cell Therapy</keyword>
	<keyword>Autologous Cell Transplantation</keyword>
	<keyword>Muscle-derived Cell</keyword>
	<keyword>Anal Incontinence</keyword>
	<keyword>Rectal Diseases</keyword>
	<keyword>Intestinal Diseases</keyword>
	<keyword>Gastrointestinal Diseases</keyword>
	<keyword>Urinary Incontinence</keyword>
</DOC>